A Study on Building a Voice Cohort for the Development of a Non-face-to-face Machine Learning Diagnostic and Monitoring Platform Using Voice Analysis and Various Sensors in Patients With Dysphagia.
Launched by SEOUL NATIONAL UNIVERSITY HOSPITAL · Jun 26, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to understand how changes in a person's voice can help diagnose and monitor swallowing difficulties, known as dysphagia. Researchers aim to collect data by analyzing voice recordings and using sensors placed on the throat to see how voice patterns change when someone has trouble swallowing. This information could lead to the development of a new system for monitoring these issues without needing face-to-face visits.
To participate in this study, you need to be at least 19 years old, scheduled for a specific swallowing test called a VFSS (Videofluoroscopic Swallowing Study), and able to make simple sounds or short sentences. You should also be comfortable with having a sensor attached to your throat. If you agree to join the trial, you will be helping researchers gather important information that could improve how swallowing problems are diagnosed and managed. It's important to note that some individuals may not be able to participate due to specific health conditions or if they are unable to follow instructions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Those who are 19 years of age or older and do not fall under the exclusion criteria
- • Patients scheduled for VFSS test
- • Patients who can record voices such as "Ah.", "Ummm\~\~\~", short sentences
- • Patients who can attach sensor on their throat
- • Those who voluntarily consent to the clinical trial
- Exclusion Criteria:
- • Those who do not agree to participate in this study
- • Patients who can not follow Step 1 instructions
- • Patients who can not vocalize or follow to speak
- • Patients who cannot apply the sensor due to skin allergy or hypersensitivity to sensor attachment
- • Other who have comorbidities (e.g., maligant tumors, blood clotting abnormalities, etc.) that are inappropriate for clinical trial participation by the judgment of the researcher 6) Other who are judged by the researcher to be unsuitable for this clinical trial.
About Seoul National University Hospital
Seoul National University Hospital (SNUH) is a leading medical institution in South Korea, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, SNUH integrates cutting-edge scientific inquiry with patient-centered care, facilitating the development of novel therapies and treatment protocols. The hospital boasts a diverse range of specialized departments and a robust infrastructure for conducting clinical studies, ensuring rigorous adherence to ethical standards and regulatory compliance. By fostering collaboration among multidisciplinary teams, SNUH aims to contribute significantly to global medical advancements and improve patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seongnam Si, Gyeonggi Do, Korea, Republic Of
Patients applied
Trial Officials
Juseok Ryu, M.D, PhD
Study Director
Seoul National University Bundang Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials